The new NCCN guidelines for immunotherapy-related toxicities

Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a post on X:

“The new ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines address a wide range of immunotherapy-related toxicities, including those associated with ICI, CAR T-cell therapy, and lymphocyte engagers.”